Atabak Mokari
2021 - Corcept Therapeutics
In 2021, Atabak Mokari earned a total compensation of $7M as Chief Financial Officer at Corcept Therapeutics.
Compensation breakdown
| Bonus | $219,977 |
|---|---|
| Option Awards | $6,411,662 |
| Salary | $390,000 |
| Total | $7,021,639 |
Mokari received $6.4M in option awards, accounting for 91% of the total pay in 2021.
Mokari also received $220K in bonus and $390K in salary.
Rankings
In 2021, Atabak Mokari's compensation ranked 1,738th out of 12,415 executives tracked by ExecPay. In other words, Mokari earned more than 86.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,738 out of 12,415 | 86th |
Division Manufacturing | 642 out of 5,505 | 88th |
Major group Chemicals And Allied Products | 237 out of 2,375 | 90th |
Industry group Drugs | 199 out of 2,096 | 91st |
Industry Pharmaceutical Preparations | 135 out of 1,546 | 91st |
Source: SEC filing on April 25, 2022.
Mokari's colleagues
We found four more compensation records of executives who worked with Atabak Mokari at Corcept Therapeutics in 2021.